The emerging approach of this peptide represents a major development in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide targets two pathways – GLP-1 and GIP – leading to improved https://tirzepatidepeptide065611.activablog.com/40965647/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment